| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| ABCC2 | C8A | ENSPPYP00000002970 | ENSPPYP00000001517 | ATP binding cassette subfamily C member 2. | Complement C8 alpha chain. | 0.759 |
| ABCC2 | SGCD | ENSPPYP00000002970 | ENSPPYP00000017884 | ATP binding cassette subfamily C member 2. | Sarcoglycan delta. | 0.687 |
| ABCC2 | SLC22A1 | ENSPPYP00000002970 | ENSPPYP00000019207 | ATP binding cassette subfamily C member 2. | Solute carrier family 22 member 1. | 0.550 |
| ABCC2 | SLC22A2 | ENSPPYP00000002970 | ENSPPYP00000019208 | ATP binding cassette subfamily C member 2. | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | 0.495 |
| ABCC2 | SLC44A5 | ENSPPYP00000002970 | ENSPPYP00000001432 | ATP binding cassette subfamily C member 2. | SLC44A5 isoform 1; Belongs to the CTL (choline transporter-like) family. | 0.790 |
| C8A | ABCC2 | ENSPPYP00000001517 | ENSPPYP00000002970 | Complement C8 alpha chain. | ATP binding cassette subfamily C member 2. | 0.759 |
| C8A | SGCD | ENSPPYP00000001517 | ENSPPYP00000017884 | Complement C8 alpha chain. | Sarcoglycan delta. | 0.750 |
| C8A | SLC44A5 | ENSPPYP00000001517 | ENSPPYP00000001432 | Complement C8 alpha chain. | SLC44A5 isoform 1; Belongs to the CTL (choline transporter-like) family. | 0.796 |
| PPT1 | SLC44A5 | ENSPPYP00000001728 | ENSPPYP00000001432 | Palmitoyl-protein thioesterase 1. | SLC44A5 isoform 1; Belongs to the CTL (choline transporter-like) family. | 0.927 |
| SGCD | ABCC2 | ENSPPYP00000017884 | ENSPPYP00000002970 | Sarcoglycan delta. | ATP binding cassette subfamily C member 2. | 0.687 |
| SGCD | C8A | ENSPPYP00000017884 | ENSPPYP00000001517 | Sarcoglycan delta. | Complement C8 alpha chain. | 0.750 |
| SGCD | SLC44A5 | ENSPPYP00000017884 | ENSPPYP00000001432 | Sarcoglycan delta. | SLC44A5 isoform 1; Belongs to the CTL (choline transporter-like) family. | 0.787 |
| SLC22A1 | ABCC2 | ENSPPYP00000019207 | ENSPPYP00000002970 | Solute carrier family 22 member 1. | ATP binding cassette subfamily C member 2. | 0.550 |
| SLC22A1 | SLC22A2 | ENSPPYP00000019207 | ENSPPYP00000019208 | Solute carrier family 22 member 1. | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | 0.924 |
| SLC22A1 | SLC22A3 | ENSPPYP00000019207 | ENSPPYP00000019210 | Solute carrier family 22 member 1. | Solute carrier family 22 member 3. | 0.907 |
| SLC22A1 | SLC22A5 | ENSPPYP00000019207 | ENSPPYP00000017626 | Solute carrier family 22 member 1. | SLC22A5 isoform 1. | 0.930 |
| SLC22A1 | SLC44A3 | ENSPPYP00000019207 | ENSPPYP00000001317 | Solute carrier family 22 member 1. | SLC44A3 isoform 1; Belongs to the CTL (choline transporter-like) family. | 0.909 |
| SLC22A1 | SLC44A4 | ENSPPYP00000019207 | ENSPPYP00000018411 | Solute carrier family 22 member 1. | SLC44A4 isoform 2; Belongs to the CTL (choline transporter-like) family. | 0.927 |
| SLC22A1 | SLC44A5 | ENSPPYP00000019207 | ENSPPYP00000001432 | Solute carrier family 22 member 1. | SLC44A5 isoform 1; Belongs to the CTL (choline transporter-like) family. | 0.915 |
| SLC22A2 | ABCC2 | ENSPPYP00000019208 | ENSPPYP00000002970 | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | ATP binding cassette subfamily C member 2. | 0.495 |